Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment [ADULT CARDIAC]
CONCLUSIONS
Ticagrelor discontinuation >72 h and clopidogrel discontinuation >120 h prior to surgery were not associated with an increased risk of bleeding-related complications. Based on these findings, a period of ticagrelor discontinuation shorter than advised by current international guidelines might be justifiable.
Source: European Journal of Cardio-Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tomsic, A., Schotborgh, M. A., Manshanden, J. S. J., Li, W. W. L., de Mol, B. A. J. M. Tags: Molecular biology, History ADULT CARDIAC Source Type: research
More News: Biology | Bleeding | Cardiology | Cardiovascular & Thoracic Surgery | Clopidogrel | Coronary Artery Bypass Graft | Heart | Molecular Biology | Plavix | Study